These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 33256299)

  • 21. Noncoding RNAs as novel biomarkers in pancreatic cancer: what do we know?
    Previdi MC; Carotenuto P; Zito D; Pandolfo R; Braconi C
    Future Oncol; 2017 Feb; 13(5):443-453. PubMed ID: 27841659
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of selected microRNAs in pancreatic ductal adenocarcinoma: is there a relation to tumor morphology, progression and patient's outcome?
    Szabo A; Gurlich R; Liberko M; Soumarova R; Vernerova Z; Mandys V; Popov A
    Neoplasma; 2020 Sep; 67(5):1170-1181. PubMed ID: 32567937
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma miRNAs in diagnosis and prognosis of pancreatic cancer: A miRNA expression analysis.
    Zhou X; Lu Z; Wang T; Huang Z; Zhu W; Miao Y
    Gene; 2018 Oct; 673():181-193. PubMed ID: 29913239
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of Blood Plasma MicroRNAs to Enable Identification of Patients with Pancreatic Ductal Adenocarcinoma Who Will Benefit from Surgical Resection.
    Gablo N. A; Procházka V; Hlavsa J; Kiss I; Srovnal J; Kala Z; Slabý O
    Klin Onkol; 2019; 32(Suppl 1):174-176. PubMed ID: 31064193
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dysregulation of key microRNAs in pancreatic cancer development.
    Baradaran B; Shahbazi R; Khordadmehr M
    Biomed Pharmacother; 2019 Jan; 109():1008-1015. PubMed ID: 30551350
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNAs as biomarkers and perspectives in the therapy of pancreatic cancer.
    Xia T; Chen XY; Zhang YN
    Mol Cell Biochem; 2021 Dec; 476(12):4191-4203. PubMed ID: 34324119
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Noncoding Rnas Emerging as Novel Biomarkers in Pancreatic Cancer.
    Garajová I; Balsano R; Tommasi C; Giovannetti E
    Curr Pharm Des; 2018; 24(39):4601-4604. PubMed ID: 30659532
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Noncoding RNAs in drug-resistant pancreatic cancer: A review.
    Lin Z; Lu S; Xie X; Yi X; Huang H
    Biomed Pharmacother; 2020 Nov; 131():110768. PubMed ID: 33152930
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of a six-miRNA panel in serum benefiting pancreatic cancer diagnosis.
    Zou X; Wei J; Huang Z; Zhou X; Lu Z; Zhu W; Miao Y
    Cancer Med; 2019 Jun; 8(6):2810-2822. PubMed ID: 31006985
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current and New Challenges in the Management of Pancreatic Neuroendocrine Tumors: The Role of miRNA-Based Approaches as New Reliable Biomarkers.
    Havasi A; Sur D; Cainap SS; Lungulescu CV; Gavrilas LI; Cainap C; Vlad C; Balacescu O
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163032
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNAs in the prognosis and therapy of colorectal cancer: From bench to bedside.
    To KK; Tong CW; Wu M; Cho WC
    World J Gastroenterol; 2018 Jul; 24(27):2949-2973. PubMed ID: 30038463
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MiR-21, miR-34a, miR-198 and miR-217 as diagnostic and prognostic biomarkers for chronic pancreatitis and pancreatic ductal adenocarcinoma.
    Vychytilova-Faltejskova P; Kiss I; Klusova S; Hlavsa J; Prochazka V; Kala Z; Mazanec J; Hausnerova J; Kren L; Hermanova M; Lenz J; Karasek P; Vyzula R; Slaby O
    Diagn Pathol; 2015 Apr; 10():38. PubMed ID: 25908274
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Roles of MicroRNA in Pancreatic Cancer Progression.
    Kt RD; Karthick D; Saravanaraj KS; Jaganathan MK; Ghorai S; Hemdev SP
    Cancer Invest; 2022 Sep; 40(8):700-709. PubMed ID: 35333689
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA-1469-5p promotes the invasion and proliferation of pancreatic cancer cells via direct regulating the NDRG1/NF-κB/E-cadherin axis.
    Liu J; Zhu C; Zhang L; Lu H; Wang Z; Lv J; Fan C
    Hum Cell; 2020 Oct; 33(4):1176-1185. PubMed ID: 32757096
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional and Potential Therapeutic Implication of MicroRNAs in Pancreatic Cancer.
    Pal A; Ojha A; Ju J
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139352
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulating MicroRNAs as Noninvasive Diagnostic and Prognostic Biomarkers in Pancreatic Cancer: A Review.
    Khan IA; Saraya A
    J Gastrointest Cancer; 2023 Sep; 54(3):720-730. PubMed ID: 36322366
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The microRNA-218 and ROBO-1 signaling axis correlates with the lymphatic metastasis of pancreatic cancer.
    He H; Di Y; Liang M; Yang F; Yao L; Hao S; Li J; Jiang Y; Jin C; Fu D
    Oncol Rep; 2013 Aug; 30(2):651-8. PubMed ID: 23733161
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential MicroRNA Expression Profiles as Potential Biomarkers for Pancreatic Ductal Adenocarcinoma.
    Zhu Y; Wang J; Wang F; Yan Z; Liu G; Ma Y; Zhu W; Li Y; Xie L; Bazhin AV; Guo X
    Biochemistry (Mosc); 2019 May; 84(5):575-582. PubMed ID: 31234772
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular subtypes of pancreatic cancer based on miRNA expression profiles have independent prognostic value.
    Namkung J; Kwon W; Choi Y; Yi SG; Han S; Kang MJ; Kim SW; Park T; Jang JY
    J Gastroenterol Hepatol; 2016 Jun; 31(6):1160-7. PubMed ID: 26644397
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma microRNA panels to diagnose pancreatic cancer: Results from a multicenter study.
    Cao Z; Liu C; Xu J; You L; Wang C; Lou W; Sun B; Miao Y; Liu X; Wang X; Zhang T; Zhao Y
    Oncotarget; 2016 Jul; 7(27):41575-41583. PubMed ID: 27223429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.